PIH39 EVALUATION OF PROPRANOLOL OFF-LABEL USE IN INFANTILE HEMANGIOMA AND EFFECTIVENESS OF RISK MINIMISATION MEASURES TO MITIGATE ADVERSE REACTIONS: A FRENCH AND GERMAN DRUG UTILIZATION STUDY
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.1220
https://www.valueinhealthjournal.com/article/S1098-3015(19)33598-3/fulltext
Section Title :
Section Order :
11069
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33598-3&doi=10.1016/j.jval.2019.09.1220